14.51BMarket Cap-25620P/E (TTM)
13.200High12.750Low7.39MVolume13.180Open13.180Pre Close95.55MTurnover0.66%Turnover RatioLossP/E (Static)1.13BShares14.46552wk High1.93P/B14.43BFloat Cap7.08552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM3.41%Amplitude3.107Historical Low12.929Avg Price1Lot Size
Teva Pharmaceutical Industries Stock Forum
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
gonna observe you
We need 12.50 1/31/24
WHY I AM BUYING RDHL....BUY HAND OVER FIST
As we're all aware, TEVA stands out as one of the premier generic labs in Israel, with even Warren Buffett having previously held a significant stake in its shares. As we gradually divest from TEVA throughout our portfolio, RDHL emerges as a substantial opportunity to allocate current funds for potential future gains. Personally, I've been acquiring shares extensively, and in my view, RDHL appears to be a potential blockbuste...
No comment yet